Ashley Vo PharmD

Ashley A. Vo, PharmD, is the Administrative Director of the Transplant Immunotherapy Program at the Comprehensive Transplant Center at Cedars-Sinai Medical Center in Los Angeles California, for the past 18 years, and Professor of Pediatrics at the David Geffen School of Medicine at UCLA. Dr. Vo earned her Doctor of Pharmacy degree at the University of Southern California in Los Angeles. She completed a General Practice Residency and a Specialty Residency in Administration, both at Cedars-Sinai Medical Center. Dr. Vo's research has been in advancing the field of desensitization for the highly HLA sensitized patients awaiting for living donor or deceased donor kidney transplantation. Patients, Nationally and Internationally, are referred to the Transplant Immunotherapy Program for desensitization and for transplantation. This program also specializes in ABO-incompatible transplant and in the development of novel therapeutics for prevention and treatment of antibody mediated rejection in kidney transplantation. Dr. Vo directs the clinical research group and is a Co-Investigator for all Kidney Transplant Investigator Initiated Trials and Industry sponsored trials. Dr. Vo also serves as an ad hoc reviewer for Transplantation, American Journal of Transplantation, Journal of Immunology, etc. and has published in journals including New England Journal of Medicine, Transplantation, American Journal of Transplantation, World Journal of Nephrology, and Immunotherapy. Dr. Vo was awarded AST Clinician of Distinction in 2014, a prestigious award that recognizes clinical excellence and the creative scholarship brings to the field of transplantation and Fellow of the American Society of Transplant in 2016.